Letermovir coadministration and tacrolimus concentration-to-dose ratios before and after intravenous-to-oral conversion in allogeneic hematopoietic stem cell transplant recipients receiving isavuconazole.

Cresemba (isavuconazonium sulfate) - Astellas, Basilea

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42611513

Ayumu Ito; Hironobu Hashimoto; Takahiro Fukuda; Toshihisa Nakashima; Yoshihiro Inamoto

Aug 19, 2026